DOCSLIB.ORG

An Investigation Into the Function and Regulation of ERG Exon 7B

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

An Investigation Into The Function and Regulation Of ERG Exon 7b Samantha Jumbe A thesis submitted in partial fulfilment of the requirements of the University of the West of England, Bristol for the degree of Doctor of Philosophy Department of Applied Science, Faculty of Health and Applied Sciences, University of the West of England June 2019 ABSTRACT The ETS family transcription factor ERG is a key oncoprotein in bone, blood, vascular and most notably prostate cancer where it is activated in at least 50% of cases. Of the several splice isoforms of ERG with variable biological activity those that include the cassette exon 7b are associated with aggressiveness and progression of disease in prostate cancer. Inclusion of exon 7b adds 24 amino- acids in frame to the central ‘alternative domain’ which also contains binding sites for other transcriptional regulators. Alignment of the amino acids of exon 7b showed it is evolutionary conserved in echinoderms emphasizing its functional importance. Splice switching oligonucleotides (SSO) targeting the splice sites for exon 7b were designed to induce exon 7b skipping. Successful SSO-induced skipping of exon 7b in the osteosarcoma MG63 cell line resulted in decreased cell migration, invasion and proliferation and increased apoptosis in vitro. ERG was shown to bind to the promoter of tissue non-specific alkaline phosphatase, a marker of cell differentiation, and SSO-induced skipping of exon 7b attenuated its expression. Moreover several splicing regulatory elements and proteins were identified using bioinformatics prediction methods and an RNA pull down of the 3´ splice site of exon 7b identified several potential splicing regulatory proteins for this exon. This study provides evidence that the inclusion of exon 7b, which encodes the full length transactivation domain enhances the oncogenic activity of ERG in vitro. Further refinement of in vivo experimentation is required but if successful SSOs that target oncogenes could potentially be developed as therapeutic agents. The study also highlights the requirement to understand splicing regulation of disease associated splicing events in ETS transcription factors and has provided pilot data for further study of ERG exon 7b splicing regulation. For those I love Samantha Jumbe- June 2019 1 ACKNOWLEDGEMENTS My sincere gratitude and appreciation go to my supervisors Dr Michael Ladomery, Dr Ian Wilson and Dr Bahareh Vahabi. Mike your tireless commitment and encouragement have been spurred me along and allowed me to develop my confidence and capabilities as a scientist. Thank you for your always open door, never ending time and patience and mostly for being there for me in the most difficult time. Ian for help with techniques and statistics and helping me remember that science is a creative discipline. For a listening ear and fresh perspectives - Bahareh thank you. I would like to acknowledge and thank my collaborators. Dr Sebastian Oltean (University of Exeter) and Dr Sean Porazinski (Ladomery Lab) for the xenograft work, Dr Lee Spraggon for advice on design and testing of SSOs and the RNAomics Platform team at the University of Sherbrooke, Canada for the high- throughput PCR analysis. I would like to thank the Malawi Government Scholarship Fund for funding this research and the University of the West of England for providing the research facilities to conduct the research in. Thank you to Kayla Friedman and Malcolm Morgan of the Centre for Sustainable Development, University of Cambridge, UK for producing the Microsoft Word thesis template used to produce this document. Thanks go to the superhero technical team of the CRIB labs with special thanks to David Corry and Dr Jeff Davey. All the fantastic members of Ladomery Lab and CRIB- thank you for the laughs, ideas and inspiration. 2 Samantha Jumbe- June 2019 So many friends who are like family – thank you for your prayers and so much more. My parents, sisters, brothers, nieces and nephew who are my most precious possession and have provided unsurpassable sustenance and wisdom. My niece Nina for always checking up on how my work on finding a cure for cancer was going (it’s still a work in progress). I could not be without all of your remarkable love and belief in me. A special mention for my late uncle Luke, and other men like him who fought prostate cancer. Your braveness was my inspiration to embark on this journey. “To Him who is able to do immeasurably more than all we ask or imagine, according to his power that is at work within us” Ephesians 3:20 (NIV) Samantha Jumbe- June 2019 3 ABBREVIATIONS AND ACRONYMS 1,25D calcitriol the active metabolite of vitamin D3 AMKL acute megakaryoblastic leukaemia AML acute myeloid leukaemia AP1 activator protein 1 AS alternative splicing ASO antisense oligonucleotide ASPCR alternative splicing using endpoint PCR coupled with microcapillary electrophoresis BCL-X B-cell lymphoma-extra-large BPS branch point site BRAF B-Raf Proto-Oncogene, Serine/Threonine Kinase BRCA1 breast cancer 1 CDK cyclin dependent kinase cDNA complementary DNA CELF CUGBP ELAV-like family member ChIP chromatin immunoprecipitation CLK cdc2-like kinase c-Myc MYC Proto-Oncogene, BHLH Transcription Factor 4 Samantha Jumbe- June 2019 CRISPR-Cas 9 Clustered Regularly Interspaced Short Palindromic Repeats CRISPR associated protein 9 CXCL12 C-X-C motif chemokine ligand 12 CXCR4 C-X-C motif chemokine receptor 4 DAPI 4′,6-diamidino-2-phenylindole DEF docking site for ERK DMD Duchenne muscular dystrophy DNA deoxyribonucleic acid DSCAM Downs syndrome cell adhesion molecule ELAVL1 ELAV Like RNA Binding Protein 1 EMT epithelial-mesenchymal transition ENCODE The Encyclopedia of DNA Elements ERG ETS-related gene or v-ets avian erythroblastosis virus E26 oncogene homolog ERK extracellular signal-regulated kinase ESE exonic splicing enhancer ESS exonic splicing silencer ETS E-26 transformation specific FAM98B Family With Sequence Similarity 98 Member B FHBP (3S)1-fluoro-3-hydroxy-4-(oleoyloxy)butyl-1-phosphonate, a synthetic analogue of LPA Samantha Jumbe- June 2019 5 FITC Fluorescein isothiocyanate G4 G-quadruplex GTEx Genotype-Tissue Expression HDR homology-directed repair hnRNP heterogeneous nuclear ribonucleoprotein ISE intronic splicing enhancer ISS intronic splicing silencer kDa kilodalton LPA lysophosphatidic acid MAPK mitogen-activated protein kinase mRNA messenger RNA MSI2 musashi RNA binding protein 2 ng nanogram NHEJ non-homologous end joining nM nanomolar NRG Neuroglian Nucleic acid bases A adenosine, T thymine, G guanine, C cytosine and U uracil PCa prostate cancer PCBP poly (rC) binding protein 6 Samantha Jumbe- June 2019 p-NP p-nitrophenol p-NPP p-nitrophenylphosphate PRAD prostate adenocarcinoma Pre-mRNA pre-messenger RNA PS phosphorothioate PSI percent spliced in PSM peptide spectrum match PTBP1 polypyrimidine tract-binding protein 1 qPCR quantitative polymerase chain reaction RBP RNA binding protein RNAPII RNA polymerase II RNA ribonucleic acid RNA-seq RNA sequencing RNPS1 RNA binding protein with serine rich domain 1 RPKM reads per kilobase transcript per million RT-PCR reverse transcriptase polymerase chain reaction SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis SELEX systematic evolution of ligands by exponential enrichment SF splice factor SF3A1 splice factor 3 subunit 1 Samantha Jumbe- June 2019 7 SF3B4 splice factor 3b subunit 4 SFPQ Splicing factor proline and glutamine rich siRNA small interfering RNA Sm smith antigen SMA Spinal muscular atrophy smRNA small nuclear RNA snRNP small nuclear ribonucleoprotein SNW1 SNW domain containing 1 SR serine-arginine rich proteins SR-A1 steroid receptor RNA activator 1 SRE splicing regulatory element SRPK serine-arginine protein kinase SRSF serine-arginine splice factor SSO splice switching oligonucleotide SXL Sex-lethal T-ALL T-cell acute lymphoblastic leukaemia TARBP1 transactivation response RNA-binding protein 1 TCGA The Cancer Genome Atlas TCR T-cell receptor TNSALP tissue non-specific alkaline phosphatase 8 Samantha Jumbe- June 2019 UTR untranslated region VDR vitamin D receptor Wnt Wingless-related integration site μM micromolar Samantha Jumbe- June 2019 9 CONTENTS 1 Introduction ............................................................................................21 1.1 Alternative splicing ............................................................................22 1.1.1 Prevalence of alternative splicing ................................................. 24 1.1.2 Specificity and complexity of splicing ........................................... 25 1.1.3 Splicing regulatory elements and proteins involved in splicing regulation ................................................................................................ 27 1.1.4 The splicing reaction .................................................................... 32 1.1.5 Alternative splicing and cancer .................................................... 38 1.2 E26-transformation specific (ETS) family of transcription factors .....41 1.2.1 Transcription factors and gene expression .................................. 41 1.2.2 Structure and binding specificity of ETS transcription factors ...... 43 1.2.3 Expression and biological function of ETS transcription factors ... 48 1.3 The ERG transcription factor ............................................................50 1.3.1 Structure and isoforms ................................................................. 50 1.3.2 ERG and Cancer .........................................................................
Recommended publications
  • Examination of the Transcription Factors Acting in Bone Marrow

    Examination of the Transcription Factors Acting in Bone Marrow

    THESIS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (PHD) Examination of the transcription factors acting in bone marrow derived macrophages by Gergely Nagy Supervisor: Dr. Endre Barta UNIVERSITY OF DEBRECEN DOCTORAL SCHOOL OF MOLECULAR CELL AND IMMUNE BIOLOGY DEBRECEN, 2016 Table of contents Table of contents ........................................................................................................................ 2 1. Introduction ............................................................................................................................ 5 1.1. Transcriptional regulation ................................................................................................... 5 1.1.1. Transcriptional initiation .................................................................................................. 5 1.1.2. Co-regulators and histone modifications .......................................................................... 8 1.2. Promoter and enhancer sequences guiding transcription factors ...................................... 11 1.2.1. General transcription factors .......................................................................................... 11 1.2.2. The ETS superfamily ..................................................................................................... 17 1.2.3. The AP-1 and CREB proteins ........................................................................................ 20 1.2.4. Other promoter specific transcription factor families ...................................................
  • Sexual Dimorphism in Brain Transcriptomes of Amami Spiny Rats (Tokudaia Osimensis): a Rodent Species Where Males Lack the Y Chromosome Madison T

    Sexual Dimorphism in Brain Transcriptomes of Amami Spiny Rats (Tokudaia Osimensis): a Rodent Species Where Males Lack the Y Chromosome Madison T

    Ortega et al. BMC Genomics (2019) 20:87 https://doi.org/10.1186/s12864-019-5426-6 RESEARCHARTICLE Open Access Sexual dimorphism in brain transcriptomes of Amami spiny rats (Tokudaia osimensis): a rodent species where males lack the Y chromosome Madison T. Ortega1,2, Nathan J. Bivens3, Takamichi Jogahara4, Asato Kuroiwa5, Scott A. Givan1,6,7,8 and Cheryl S. Rosenfeld1,2,8,9* Abstract Background: Brain sexual differentiation is sculpted by precise coordination of steroid hormones during development. Programming of several brain regions in males depends upon aromatase conversion of testosterone to estrogen. However, it is not clear the direct contribution that Y chromosome associated genes, especially sex- determining region Y (Sry), might exert on brain sexual differentiation in therian mammals. Two species of spiny rats: Amami spiny rat (Tokudaia osimensis) and Tokunoshima spiny rat (T. tokunoshimensis) lack a Y chromosome/Sry, and these individuals possess an XO chromosome system in both sexes. Both Tokudaia species are highly endangered. To assess the neural transcriptome profile in male and female Amami spiny rats, RNA was isolated from brain samples of adult male and female spiny rats that had died accidentally and used for RNAseq analyses. Results: RNAseq analyses confirmed that several genes and individual transcripts were differentially expressed between males and females. In males, seminal vesicle secretory protein 5 (Svs5) and cytochrome P450 1B1 (Cyp1b1) genes were significantly elevated compared to females, whereas serine (or cysteine) peptidase inhibitor, clade A, member 3 N (Serpina3n) was upregulated in females. Many individual transcripts elevated in males included those encoding for zinc finger proteins, e.g.
  • Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?

    Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?

    Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement.
  • Análise Correlacional Entre a Expressão Dos Fatores De Splicing E a Ocorrência De Splicing Alternativo Em Tecidos Humanos E De Camundongos

    Análise Correlacional Entre a Expressão Dos Fatores De Splicing E a Ocorrência De Splicing Alternativo Em Tecidos Humanos E De Camundongos

    ANÁLISE CORRELACIONAL ENTRE A EXPRESSÃO DOS FATORES DE SPLICING E A OCORRÊNCIA DE SPLICING ALTERNATIVO EM TECIDOS HUMANOS E DE CAMUNDONGOS JULIO CÉSAR NUNES Dissertação apresentada à Fundação Antônio Prudente para a obtenção do título de Mestre em Ciências Área de Concentração: Oncologia Orientador: Dr. Sandro José de Souza São Paulo 2008 Livros Grátis http://www.livrosgratis.com.br Milhares de livros grátis para download. FICHA CATALOGRÁFICA Preparada pela Biblioteca da Fundação Antônio Prudente Nunes, Julio César Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos / Julio César Nunes – São Paulo, 2008. 79p. Dissertação (Mestrado) - Fundação Antônio Prudente. Curso de Pós-Graduação em Ciências - Área de concentração: Oncologia. Orientador: Sandro José Souza Descritores: 1. SPLICING ALTERNATIVO 2. BIOLOGIA MOLECULAR COMPUTACIONAL 3. CÂNCER 4. GENOMICA. AGRADECIMENTOS Agradeço à FAPESP e CAPES pela bolsa de Mestrado. Ao Sandro José de Souza agradeço toda orientação e conhecimento oferecido. Meus especiais agradecimentos ao Pedro Alexandre Favoretto Galante que dedicou atenção a minha formação no processo de Pós-Graduação na Fundação Antônio Prudente, bem como pela sua oficiosa co-orientação ao projeto de pesquisa. À grande família e amigos pela dedicação e incentivo a minha formação acadêmica. À Fundação Antônio Prudente, Hospital do Câncer e Instituto Ludwig de Pesquisa sobre o Câncer dedico os meus nobres agradecimentos finais. RESUMO Nunes JC. Análise correlacional entre a expressão dos fatores de splicing e a ocorrência de splicing alternativo em tecidos humanos e de camundongos. São Paulo; 2007. [Dissertacão de Mestrado - Fundação Antônio Prudente] Splicing alternativo desempenha uma significante função no aumento da complexidade genômica, produzindo um extenso número de mRNA e isoformas protéicas.
  • (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation

    (P -Value<0.05, Fold Change≥1.4), 4 Vs. 0 Gy Irradiation

    Table S1: Significant differentially expressed genes (P -Value<0.05, Fold Change≥1.4), 4 vs. 0 Gy irradiation Genbank Fold Change P -Value Gene Symbol Description Accession Q9F8M7_CARHY (Q9F8M7) DTDP-glucose 4,6-dehydratase (Fragment), partial (9%) 6.70 0.017399678 THC2699065 [THC2719287] 5.53 0.003379195 BC013657 BC013657 Homo sapiens cDNA clone IMAGE:4152983, partial cds. [BC013657] 5.10 0.024641735 THC2750781 Ciliary dynein heavy chain 5 (Axonemal beta dynein heavy chain 5) (HL1). 4.07 0.04353262 DNAH5 [Source:Uniprot/SWISSPROT;Acc:Q8TE73] [ENST00000382416] 3.81 0.002855909 NM_145263 SPATA18 Homo sapiens spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA [NM_145263] AA418814 zw01a02.s1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:767978 3', 3.69 0.03203913 AA418814 AA418814 mRNA sequence [AA418814] AL356953 leucine-rich repeat-containing G protein-coupled receptor 6 {Homo sapiens} (exp=0; 3.63 0.0277936 THC2705989 wgp=1; cg=0), partial (4%) [THC2752981] AA484677 ne64a07.s1 NCI_CGAP_Alv1 Homo sapiens cDNA clone IMAGE:909012, mRNA 3.63 0.027098073 AA484677 AA484677 sequence [AA484677] oe06h09.s1 NCI_CGAP_Ov2 Homo sapiens cDNA clone IMAGE:1385153, mRNA sequence 3.48 0.04468495 AA837799 AA837799 [AA837799] Homo sapiens hypothetical protein LOC340109, mRNA (cDNA clone IMAGE:5578073), partial 3.27 0.031178378 BC039509 LOC643401 cds. [BC039509] Homo sapiens Fas (TNF receptor superfamily, member 6) (FAS), transcript variant 1, mRNA 3.24 0.022156298 NM_000043 FAS [NM_000043] 3.20 0.021043295 A_32_P125056 BF803942 CM2-CI0135-021100-477-g08 CI0135 Homo sapiens cDNA, mRNA sequence 3.04 0.043389246 BF803942 BF803942 [BF803942] 3.03 0.002430239 NM_015920 RPS27L Homo sapiens ribosomal protein S27-like (RPS27L), mRNA [NM_015920] Homo sapiens tumor necrosis factor receptor superfamily, member 10c, decoy without an 2.98 0.021202829 NM_003841 TNFRSF10C intracellular domain (TNFRSF10C), mRNA [NM_003841] 2.97 0.03243901 AB002384 C6orf32 Homo sapiens mRNA for KIAA0386 gene, partial cds.
  • Pirfenidone Is Renoprotective in Diabetic Kidney Disease

    Pirfenidone Is Renoprotective in Diabetic Kidney Disease

    BASIC RESEARCH www.jasn.org Pirfenidone Is Renoprotective in Diabetic Kidney Disease ʈ Satish P. RamachandraRao,*†‡ Yanqing Zhu,‡ Timothy Ravasi,§ Tracy A. McGowan,‡ Irene Toh,‡ Stephen R. Dunn,‡¶ Shinichi Okada,*† Michael A. Shaw,** and Kumar Sharma*†‡ *Center for Renal Translational Medicine, Division of Nephrology-Hypertension, Department of Medicine, and ʈ §Department of Bioengineering, Jacobs School of Engineering, University of California, San Diego, Scripps NeuroAIDS Preclinical Studies Centre, and †Veterans Administration San Diego Healthcare System, La Jolla, California, ‡Center for Novel Therapies in Kidney Disease, Department of Medicine, ¶Cancer Genomics Facility, Kimmel Cancer Center, and **Proteomics and Mass Spectrometry Core Facility, Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania ABSTRACT Although several interventions slow the progression of diabetic nephropathy, current therapies do not halt progression completely. Recent preclinical studies suggested that pirfenidone (PFD) prevents fibrosis in various diseases, but the mechanisms underlying its antifibrotic action are incompletely understood. Here, we evaluated the role of PFD in regulation of the extracellular matrix. In mouse mesangial cells, PFD decreased TGF-␤ promoter activity, reduced TGF-␤ protein secretion, and inhibited TGF-␤–induced Smad2-phosphor- ylation, 3TP-lux promoter activity, and generation of reactive oxygen species. To explore the therapeutic potential of PFD, we administered PFD to 17-wk-old db/db mice for 4 wk. PFD treatment significantly reduced mesangial matrix expansion and expression of renal matrix genes but did not affect albuminuria. Using liquid chromatography with subsequent electrospray ionization tandem mass spectrometry, we iden- tified 21 proteins unique to PFD-treated diabetic kidneys. Analysis of gene ontology and protein–protein interactions of these proteins suggested that PFD may regulate RNA processing.
  • Single-Nucleotide Human Disease Mutation Inactivates a Blood- Regenerative GATA2 Enhancer

    Single-Nucleotide Human Disease Mutation Inactivates a Blood- Regenerative GATA2 Enhancer

    Single-nucleotide human disease mutation inactivates a blood- regenerative GATA2 enhancer Alexandra A. Soukup, … , Sunduz Keles, Emery H. Bresnick J Clin Invest. 2019;129(3):1180-1192. https://doi.org/10.1172/JCI122694. Research Article Hematology Stem cells Graphical abstract Find the latest version: https://jci.me/122694/pdf RESEARCH ARTICLE The Journal of Clinical Investigation Single-nucleotide human disease mutation inactivates a blood-regenerative GATA2 enhancer Alexandra A. Soukup,1,2 Ye Zheng,1,3 Charu Mehta,1,2 Jun Wu,4 Peng Liu,1,2 Miao Cao,1,2 Inga Hofmann,1,5 Yun Zhou,1,6 Jing Zhang,1,6 Kirby D. Johnson,1,2 Kyunghee Choi,4 Sunduz Keles,1,3,7 and Emery H. Bresnick1,2 1UW-Madison Blood Research Program, Department of Cell and Regenerative Biology, Wisconsin Institutes for Medical Research, 2UW Carbone Cancer Center, and 3Department of Statistics, University of Wisconsin–Madison, Madison, Wisconsin, USA. 4Washington University School of Medicine, Saint Louis, Missouri, USA. 5Department of Pediatrics, and 6McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. 7Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA. The development and function of stem and progenitor cells that produce blood cells are vital in physiology. GATA-binding protein 2 (GATA2) mutations cause GATA-2 deficiency syndrome involving immunodeficiency, myelodysplastic syndrome, and acute myeloid leukemia. GATA-2 physiological activities necessitate that it be strictly regulated, and cell type–specific enhancers fulfill this role. The +9.5 intronic enhancer harbors multiple conserved cis-elements, and germline mutations of these cis-elements are pathogenic in humans.
  • Supporting Information

    Supporting Information

    Supporting Information Whittle et al. 10.1073/pnas.0812894106 SI Text range based on analysis on 1.5% agarose gels after reversal of In Vitro Genomic Selection. Recombinant NFI-1-GST fusion pro- cross-linking. DNA-protein complexes were precipitated with tein was immobilized on Glutathione Sepharose 4B (Amersham) anti-NFI immune serum (5 ␮l) or preimmune serum (5 ␮l) as a and C. elegans genomic DNA was used for in vitro genomic control and 5% of the input sample was set aside. Samples were selection. The fusion protein contained the NFI-1 DNA-binding processed using the ChIP assay kit (Upstate). Following reversal domain and a short downstream region. For NFI-1-GST Sepha- of the cross-links, RNase A and Proteinase K treatments, the rose preparation, 400 ml of induced DH5␣ cells expressing immunoprecipitated DNA was purified using phenol-chloro- NFI-1-GST (plasmid pGEXNFI-1) was extracted in buffer L (25 form, precipitated with ethanol, and dissolved in 50 ␮l of DNase, mM Hepes pH 7.5, 10% sucrose, 0.35 M NaCl, 5 mM DTT, 1 mM Rnase-free water. For ChIP-chip, samples were amplified by PMSF, 0.1% Nonidet P-40 and 2 mg/ml of lysozyme). The extract either ligation mediated PCR (5) or a modified Whole Genome (35 ml) was flash-frozen in 5-ml aliquots and stored at –70 °C. To Amplification protocol [Sigma; (6)] as previously described. immobilize NFI-1-GST protein on Glutathione Sepharose 4B, 5 ml of cell extract was incubated with 65 ␮l (bed volume) of Microarrays and Data Extraction.
  • WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T

    WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T

    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/174282 A2 20 December 2012 (20.12.2012) P O P C T (51) International Patent Classification: David [US/US]; 13539 N . 95th Way, Scottsdale, AZ C12Q 1/68 (2006.01) 85260 (US). (21) International Application Number: (74) Agent: AKHAVAN, Ramin; Caris Science, Inc., 6655 N . PCT/US20 12/0425 19 Macarthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 14 June 2012 (14.06.2012) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, English (25) Filing Language: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, Publication Language: English DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, (30) Priority Data: KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, 61/497,895 16 June 201 1 (16.06.201 1) US MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, 61/499,138 20 June 201 1 (20.06.201 1) US OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, 61/501,680 27 June 201 1 (27.06.201 1) u s SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, 61/506,019 8 July 201 1(08.07.201 1) u s TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
  • Supplementary Information.Pdf

    Supplementary Information.Pdf

    Supplementary Information Whole transcriptome profiling reveals major cell types in the cellular immune response against acute and chronic active Epstein‐Barr virus infection Huaqing Zhong1, Xinran Hu2, Andrew B. Janowski2, Gregory A. Storch2, Liyun Su1, Lingfeng Cao1, Jinsheng Yu3, and Jin Xu1 Department of Clinical Laboratory1, Children's Hospital of Fudan University, Minhang District, Shanghai 201102, China; Departments of Pediatrics2 and Genetics3, Washington University School of Medicine, Saint Louis, Missouri 63110, United States. Supplementary information includes the following: 1. Supplementary Figure S1: Fold‐change and correlation data for hyperactive and hypoactive genes. 2. Supplementary Table S1: Clinical data and EBV lab results for 110 study subjects. 3. Supplementary Table S2: Differentially expressed genes between AIM vs. Healthy controls. 4. Supplementary Table S3: Differentially expressed genes between CAEBV vs. Healthy controls. 5. Supplementary Table S4: Fold‐change data for 303 immune mediators. 6. Supplementary Table S5: Primers used in qPCR assays. Supplementary Figure S1. Fold‐change (a) and Pearson correlation data (b) for 10 cell markers and 61 hypoactive and hyperactive genes identified in subjects with acute EBV infection (AIM) in the primary cohort. Note: 23 up‐regulated hyperactive genes were highly correlated positively with cytotoxic T cell (Tc) marker CD8A and NK cell marker CD94 (KLRD1), and 38 down‐regulated hypoactive genes were highly correlated positively with B cell, conventional dendritic cell
  • Transcriptional Recapitulation and Subversion Of

    Transcriptional Recapitulation and Subversion Of

    Open Access Research2007KaiseretVolume al. 8, Issue 7, Article R131 Transcriptional recapitulation and subversion of embryonic colon comment development by mouse colon tumor models and human colon cancer Sergio Kaiser¤*, Young-Kyu Park¤†, Jeffrey L Franklin†, Richard B Halberg‡, Ming Yu§, Walter J Jessen*, Johannes Freudenberg*, Xiaodi Chen‡, Kevin Haigis¶, Anil G Jegga*, Sue Kong*, Bhuvaneswari Sakthivel*, Huan Xu*, Timothy Reichling¥, Mohammad Azhar#, Gregory P Boivin**, reviews Reade B Roberts§, Anika C Bissahoyo§, Fausto Gonzales††, Greg C Bloom††, Steven Eschrich††, Scott L Carter‡‡, Jeremy E Aronow*, John Kleimeyer*, Michael Kleimeyer*, Vivek Ramaswamy*, Stephen H Settle†, Braden Boone†, Shawn Levy†, Jonathan M Graff§§, Thomas Doetschman#, Joanna Groden¥, William F Dove‡, David W Threadgill§, Timothy J Yeatman††, reports Robert J Coffey Jr† and Bruce J Aronow* Addresses: *Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA. †Departments of Medicine, and Cell and Developmental Biology, Vanderbilt University and Department of Veterans Affairs Medical Center, Nashville, TN 37232, USA. ‡McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, WI 53706, USA. §Department of Genetics and Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA. ¶Molecular Pathology Unit and Center for Cancer Research, Massachusetts deposited research General Hospital, Charlestown, MA 02129, USA. ¥Division of Human Cancer Genetics, The Ohio State University College of Medicine, Columbus, Ohio 43210-2207, USA. #Institute for Collaborative BioResearch, University of Arizona, Tucson, AZ 85721-0036, USA. **University of Cincinnati, Department of Pathology and Laboratory Medicine, Cincinnati, OH 45267, USA. ††H Lee Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. ‡‡Children's Hospital Informatics Program at the Harvard-MIT Division of Health Sciences and Technology (CHIP@HST), Harvard Medical School, Boston, Massachusetts 02115, USA.

  • Drosophila and Human Transcriptomic Data Mining Provides Evidence for Therapeutic

    Drosophila and human transcriptomic data mining provides evidence for therapeutic mechanism of pentylenetetrazole in Down syndrome Author Abhay Sharma Institute of Genomics and Integrative Biology Council of Scientific and Industrial Research Delhi University Campus, Mall Road Delhi 110007, India Tel: +91-11-27666156, Fax: +91-11-27662407 Email: [email protected] Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 Running head: Pentylenetetrazole mechanism in Down syndrome 1 Abstract Pentylenetetrazole (PTZ) has recently been found to ameliorate cognitive impairment in rodent models of Down syndrome (DS). The mechanism underlying PTZ’s therapeutic effect is however not clear. Microarray profiling has previously reported differential expression of genes in DS. No mammalian transcriptomic data on PTZ treatment however exists. Nevertheless, a Drosophila model inspired by rodent models of PTZ induced kindling plasticity has recently been described. Microarray profiling has shown PTZ’s downregulatory effect on gene expression in fly heads. In a comparative transcriptomics approach, I have analyzed the available microarray data in order to identify potential mechanism of PTZ action in DS. I find that transcriptomic correlates of chronic PTZ in Drosophila and DS counteract each other. A significant enrichment is observed between PTZ downregulated and DS upregulated genes, and a significant depletion between PTZ downregulated and DS dowwnregulated genes. Further, the common genes in PTZ Nature Precedings : hdl:10101/npre.2010.4330.1 Posted 5 Apr 2010 downregulated and DS upregulated sets show enrichment for MAP kinase pathway. My analysis suggests that downregulation of MAP kinase pathway may mediate therapeutic effect of PTZ in DS. Existing evidence implicating MAP kinase pathway in DS supports this observation.